alpha-synuclein has been researched along with ceric-oxide* in 2 studies
2 other study(ies) available for alpha-synuclein and ceric-oxide
| Article | Year |
|---|---|
Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity.
Among therapeutic proposals for amyloid-associated disorders, special attention has been given to the exploitation of nanoparticles (NPs) as promising agents against aggregation.. In this paper, the inhibitory effect of cerium oxide (CeO. It may be concluded that CeO Topics: alpha-Synuclein; Amyloid; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Cell Line, Tumor; Cerium; Congo Red; Humans; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Nanoparticles; Necrosis; RNA, Messenger; Spectrometry, Fluorescence | 2019 |
Nano-particle mediated inhibition of Parkinson's disease using computational biology approach.
Parkinson's disease (PD) arises as neurodegenerative disorder and characterized by progressive deterioration of motor functions due to forfeiture of dopamine-releasing neurons. During PD, neurons at stake loss their functionality that results into cognition impairment and forgetfulness, commonly called as dementia. Recently, nanoparticles (NPs) have been reported for easy drug delivery through blood-brain barrier (BBB) into the central nervous system (CNS) against the conventional drug delivery systems. However, present study attempted to elucidate the α-synuclein activity, a major factor casing PD, in presence of its inhibitor cerium oxide (CeO Topics: alpha-Synuclein; Blood-Brain Barrier; Cerium; Humans; Molecular Dynamics Simulation; Nanoparticles; Parkinson Disease | 2018 |